OrganoClick (ORGC.ST) Stock Analysis & AI Equity Report
OrganoClick (ORGC.ST) overview
OrganoClick (ORGC.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, OrganoClick reported revenue of SEK 106m and operating profit of SEK -31.5m; the year-end share price was 1.75 SEK and market capitalisation was SEK 178m. OrganoClick is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get OrganoClick's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About OrganoClick
OrganoClick AB develops, produces and markets bio-based chemical products and performance materials derived from cellulose and other renewable raw materials. Its portfolio includes wood protection, textile impregnation, maintenance and cleaning products, and binders and barriers for nonwoven and packaging applications. The company sells through industrial customers and consumer brands in Europe, North America and Asia.
Generate the OrganoClick report
OrganoClick is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for OrganoClick and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.